Document Detail


Cannabinoid receptor type I modulates alcohol-induced liver fibrosis.
MedLine Citation:
PMID:  21863215     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The cannabinoid system (CS) is implicated in the regulation of hepatic fibrosis, steatosis and inflammation, with cannabinoid receptors 1 and 2 (CB1 and CB2) being involved in regulation of pro- and antifibrogenic effects. Daily cannabis smoking is an independent risk factor for the progression of fibrosis in chronic hepatitis C and a mediator of experimental alcoholic steatosis. However, the role and function of CS in alcoholic liver fibrosis (ALF) is unknown so far. Thus, human liver samples from patients with alcoholic liver disease (ALD) were collected for analysis of CB1 expression. In vitro, hepatic stellate cells (HSC) underwent treatment with acetaldehyde, Δ9-tetrahydrocannabinol H₂O₂, endo- and exocannabinoids (2-arachidonoylglycerol (2-AG) and [THC]), and CB1 antagonist SR141716 (rimonabant). In vivo, CB1 knockout (KO) mice received thioacetamide (TAA)/ethanol (EtOH) to induce fibrosis. As a result, in human ALD, CB1 expression was restricted to areas with advanced fibrosis only. In vitro, acetaldehyde, H₂O₂, as well as 2-AG and THC, alone or in combination with acetaldehyde, induced CB1 mRNA expression, whereas CB1 blockage with SR141716 dose-dependently inhibited HSC proliferation and downregulated mRNA expression of fibrosis-mediated genes PCα1(I), TIMP-1 and MMP-13. This was paralleled by marked cytotoxicity of SR141716 at high doses (5-10 μmol/L). In vivo, CB1 knockout mice showed marked resistance to alcoholic liver fibrosis. In conclusion, CB1 expression is upregulated in human ALF, which is at least in part triggered by acetaldehyde (AA) and oxidative stress. Inhibition of CB1 by SR141716, or via genetic knock-out protects against alcoholic-induced fibrosis in vitro and in vivo.
Authors:
Eleonora Patsenker; Matthias Stoll; Gunda Millonig; Abbas Agaimy; Till Wissniowski; Vreni Schneider; Sebastian Mueller; Rudolf Brenneisen; Helmut K Seitz; Matthias Ocker; Felix Stickel
Related Documents :
22203485 - Cloning and the expression pattern of spätzle gene during embryonic development and bac...
21853455 - Mechanical stretch enhances col2a1 expression on chromatin by inducing sox9 nuclear tra...
21566225 - Genome-wide characterization of mir-34a induced changes in protein and mrna expression ...
21606625 - Effects of flavonoids on matrix metalloproteinase-13 expression of interleukin-1β-treat...
7969165 - The ikaros gene encodes a family of functionally diverse zinc finger dna-binding proteins.
23968725 - Arsenic induces the expressions of angiogenesis-related factors through pi3k and mapk p...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-08-19
Journal Detail:
Title:  Molecular medicine (Cambridge, Mass.)     Volume:  17     ISSN:  1528-3658     ISO Abbreviation:  Mol. Med.     Publication Date:  2011  
Date Detail:
Created Date:  2012-04-09     Completed Date:  2012-08-03     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  9501023     Medline TA:  Mol Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1285-94     Citation Subset:  IM    
Affiliation:
Department of Clinical Pharmacology and Visceral Research, University of Bern, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetaldehyde / pharmacology
Animals
Apoptosis / drug effects
Cannabinoids / pharmacology
Cell Hypoxia / drug effects
Cell Proliferation / drug effects
Collagen / metabolism
Female
Hepatic Stellate Cells / drug effects,  metabolism,  pathology
Humans
Hydrogen Peroxide / pharmacology
Inflammation / complications,  pathology
Liver / drug effects,  metabolism,  pathology
Liver Cirrhosis, Alcoholic / complications,  enzymology,  metabolism*,  pathology
Male
Matrix Metalloproteinases / genetics,  metabolism
Mice
Middle Aged
Piperidines / toxicity
Pyrazoles / toxicity
RNA, Messenger / genetics,  metabolism
Receptor, Cannabinoid, CB1 / deficiency,  metabolism*
Receptor, Cannabinoid, CB2 / metabolism
Up-Regulation / drug effects,  genetics
Chemical
Reg. No./Substance:
0/Cannabinoids; 0/Piperidines; 0/Pyrazoles; 0/RNA, Messenger; 0/Receptor, Cannabinoid, CB1; 0/Receptor, Cannabinoid, CB2; 158681-13-1/rimonabant; 75-07-0/Acetaldehyde; 7722-84-1/Hydrogen Peroxide; 9007-34-5/Collagen; EC 3.4.24.-/Matrix Metalloproteinases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endoplasmic reticulum stress implicated in the development of renal fibrosis.
Next Document:  AHR regulates WT1 genetic programming during murine nephrogenesis.